• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/8

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

8 Cards in this Set

  • Front
  • Back
major clinical features of VHL
CNA hemangioblastomas, Retinal hemangioblastomas, Renal Cell Carcinoma, Pheochromocytomas/paragangliomas, neuroendocrine tumors of pancreas, endolymphatic sac tumors, papillary cystadenomas of epididymus
CNS hemangioblastomas are
tumors throughout the CNS that are benign and unpredictable
Renal Cell Carcinomas are
accompanied by asymptomatic cysts
unpredictable growth
treatment of renal cell carcinomas
surgery, radiofrequency or cryoablation
histology of renal cell carcinoma
clear cell type
pheochromocytomas are
neuroendocrine tumors of the medulla
criteria for gene mutation analysis for VHL
pt with classical VHL disease and or first degree family members
a person from a family where germline VHL gene has been identified
pt has multicentric tumors on one organ, bilateral tumors, two organ systems affected, one VHL associated tumor at young age
patient from a family with one hemangioblastoma, renal cell carcinoma, or pheochromocytoma
Screening for VHL
eye-infancy, yearly
MRI-CNS- 10-12yrs. yearly
Abdominal US- teens, yearly
CT/MRI, audiology-symptoms
catecholamines- 2 yrs. yearly